For anyone learning more about this trial being conducted at Mayo Clinic in Rochester, here's more information.
- Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer (DAPPER) https://classic.clinicaltrials.gov/ct2/show/NCT05830838

Quote from the description "Adaptive radiotherapy is an emerging treatment technique that uses daily imaging to adjust treatment volumes, ensure accurate dose delivery, and allow the use of smaller planning target volume margins."
That just seem to make sense doesn't it?

@rgnmayo, I'm glad that this trial option is available to you. You're asking good questions and I hope others here who are enrolled in the study will chime in. In the meantime, would you mind sharing a bit more about your decision factors. Did the study team share how the treatment differs from standard treatment? And how side effects may be different?